Blueprint study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST, click here to view in clinicaltrials.gov  and can be viewed at https://www.blueprintclinicaltrials.com/clinical-trial/voyager/